RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment

Optimum Treatment for Drug-Resistant Hypertension

NCT02369081 ·Status: UNKNOWN ·Phase: PHASE4

A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)

NCT00246584 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients

NCT02515331 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

NCT00351130 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH

NCT03180593 ·Status: COMPLETED ·Phase: PHASE4

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension

NCT00353912 ·Status: COMPLETED ·Phase: PHASE3

Antihypertensive Efficacy of Fixed Combination Drug

NCT01211314 ·Status: TERMINATED ·Phase: PHASE4

A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

NCT01241487 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Beta-blocker Versus Angiotensin Receptor Blocker for Suppression of Aneurysm Expansion in Patients With Small Abdominal Aortic Aneurysm and Hypertension (BASE Trial)

NCT01904981 ·Status: COMPLETED ·Phase: PHASE4

The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension

NCT00562809 ·Status: COMPLETED ·Phase: PHASE4

Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study

NCT04030234 ·Status: COMPLETED ·Phase: NA

A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg

NCT00241137 ·Status: COMPLETED ·Phase: PHASE3

A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

NCT06273254 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Endothelin-1 Receptor Blockade in Resistant Hypertension

NCT04388124 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

NCT00523744 ·Status: COMPLETED ·Phase: PHASE3

A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

NCT06193187 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients

NCT01042392 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Two Treatment Strategies in Hypertensive Patients

NCT00171444 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

NCT00360178 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

NCT00171535 ·Status: COMPLETED ·Phase: PHASE3

Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

NCT00333489 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Leningrado 5 Association in the Treatment of Hypertension

NCT03814148 ·Status: WITHDRAWN ·Phase: PHASE3

New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering

NCT01609959 ·Status: COMPLETED ·Phase: PHASE4

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

NCT03541174 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension

NCT00219050 ·Status: COMPLETED ·Phase: PHASE3